Generate Biomedicines is trading 4.31% down at $15.21 amid a broad market selloff as Brent crude rose above $100 amid intensifying U.S.-Iran tensions.
- The S&P 500, Nasdaq Composite, and Dow Jones are all lower, with Reuters reporting that the oil surge is pressuring global markets.
- Rising oil increased inflation and energy-cost concerns, weighing on risk appetite.
- No clear company-specific negative announcement was identified. The company is scheduled to present at the Cantor Global Healthcare Conference on September 9.